Alcohol Pharmacogenetics in Mexican Americans

墨西哥裔美国人的酒精药物遗传学

基本信息

  • 批准号:
    7854437
  • 负责人:
  • 金额:
    $ 8.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-01 至 2010-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Representing one of the fastest growing ethnic groups in the United States, Hispanics accounted for 12% of the nation's population by March 2000, and suffer from higher rates of alcohol related problems as compared with those from other ethnic backgrounds (e.g., Caucasians and African Americans). This notwithstanding, genetic factors that might contribute to such risks remain poorly understood. Building upon the research infrastructure that has been established, this competitive continuation application will systematically explore and examine genetic mechanisms for alcoholism in Mexican Americans. This ongoing research program has started to identify unique genetic patterns that might be in part responsible for the heightened risk for alcoholism and alcohol associated health problems in this population. These include (1) extremely low allele frequency for both ALDH2*2 (aldehyde dehydrogenase) and ADH2*2 (alcohol dehydrogenase); (2) a relatively high rate of ADH3*2 and CYP2E1 c2 (cytochrome P4502E1) alleles; (3) association of ADH3*2, ADH2*1, DRD2 (dopamine receptor -141C Del/Ins) and serotonin transporter gene-linked polymorphic region (5-HTTLPR) with alcoholism; (4) a strong association of ADH3*2 and ADH2*1 alleles with binge drinking; and (5) association of the DRD2 Taq1 A and 1B alleles with early age of onset for drinking. In this new funding cycle, we plan to further pursue and clarify the meaning of these findings. Specifically, we will (1) expand our study to include Mexican American women with alcohol problems; (2) further examine the role of these polymorphisms, as well as their potential interactions, in relation to risks for alcoholism in Mexican American populations; (3) examine the role of these risks in relationship with the severity of alcoholism i.e. binge drinking and early onset of drinking; (4) characterize and determine the haplotype of DRD2 in association with drinking in Mexican Americans, and assess the relative advantage of haplotype vs. allelic analysis in delineating risk factors contributory to the development of alcoholism. This study will be the first to systematically examine how genetic factors modulate alcohol dependence and abuse in Mexican Americans. Results derived from such a study should not only provide for a better understanding of alcohol use and abuse among Mexican Americans, but also contribute towards a knowledge base regarding ethnic differences in alcohol pharmacogenetics and mechanisms that might be responsible for the high rate of alcoholism in this minority population.
描述(由申请人提供):西班牙裔是美国增长最快的族裔群体之一,截至 2000 年 3 月,其人口占全国人口的 12%,与其他族裔背景(例如白人和非裔美国人)相比,他们患有酒精相关问题的比例更高。尽管如此,人们对可能导致此类风险的遗传因素仍知之甚少。在已建立的研究基础设施的基础上,这项竞争性的延续申请将系统地探索和检查墨西哥裔美国人酗酒的遗传机制。这项正在进行的研究计划已开始确定独特的遗传模式,这些模式可能是导致该人群酗酒和酒精相关健康问题风险增加的部分原因。其中包括 (1) ALDH2*2(乙醛脱氢酶)和 ADH2*2(乙醇脱氢酶)的等位基因频率极低; (2) ADH3*2和CYP2E1 c2(细胞色素P4502E1)等位基因比例较高; (3)ADH3*2、ADH2*1、DRD2(多巴胺受体-141C Del/Ins)和5-羟色胺转运蛋白基因连锁多态区(5-HTTLPR)与酗酒的关联; (4) ADH3*2 和 ADH2*1 等位基因与酗酒有很强的相关性; (5) DRD2 Taq1 A 和 1B 等位基因与饮酒年龄过早的关系。在这个新的融资周期中,我们计划进一步探讨和阐明这些发现的含义。具体来说,我们将(1)扩大我们的研究范围,将有酗酒问题的墨西哥裔美国女性纳入其中; (2) 进一步研究这些多态性的作用及其潜在的相互作用,与墨西哥裔美国人酗酒的风险相关; (3) 检查这些风险与酗酒严重程度(即酗酒和过早饮酒)之间的关系; (4) 表征并确定与墨西哥裔美国人饮酒相关的 DRD2 单倍型,并评估单倍型与等位基因分析在描述导致酗酒的危险因素方面的相对优势。这项研究将首次系统地研究遗传因素如何调节墨西哥裔美国人的酒精依赖和滥用。这项研究的结果不仅应该有助于更好地了解墨西哥裔美国人的酒精使用和滥用,而且还有助于建立关于酒精药物遗传学的种族差异和可能导致该少数群体酗酒率高的机制的知识库。

项目成果

期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Polymorphisms of CYP2C19 and CYP2D6 in Israeli ethnic groups.
Nur-related receptor 1 gene polymorphisms and alcohol dependence in Mexican Americans.
  • DOI:
    10.3748/wjg.v18.i37.5276
  • 发表时间:
    2012-10
  • 期刊:
  • 影响因子:
    4.3
  • 作者:
    Yaming Wei;Yanlei Du;Y. Nie;Yu-yuan Li;Y. Wan
  • 通讯作者:
    Yaming Wei;Yanlei Du;Y. Nie;Yu-yuan Li;Y. Wan
Linkage disequilibrium blocks, haplotype structure, and htSNPs of human CYP7A1 gene.
人CYP7A1基因的连锁不平衡块,单倍型结构和HTSNP。
  • DOI:
    10.1186/1471-2156-7-29
  • 发表时间:
    2006-05-18
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Nakamoto, Kaori;Wang, Shuang;Jenison, Robert D.;Guo, Grace L.;Klaassen, Curtis D.;Wan, Yu-Jui Yvonne;Zhong, Xiao-bo
  • 通讯作者:
    Zhong, Xiao-bo
The association of exon 3 VNTR polymorphism of the dopamine receptor D4 (DRD4) gene with alcoholism in Mexican Americans.
  • DOI:
    10.1016/j.psychres.2010.02.021
  • 发表时间:
    2010-05-30
  • 期刊:
  • 影响因子:
    11.3
  • 作者:
    Du, Yanlei;Yang, Min;Yeh, Hung-Wen;Wan, Yu-Jui Yvonne
  • 通讯作者:
    Wan, Yu-Jui Yvonne
Identification of CYP2D6 impaired functional alleles in Mexican Americans.
墨西哥裔美国人中 CYP2D6 功能受损等位基因的鉴定。
  • DOI:
    10.1007/s00228-005-0044-4
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Luo,Huai-Rong;Gaedigk,Andrea;Aloumanis,Vasileios;Wan,Yu-JuiYvonne
  • 通讯作者:
    Wan,Yu-JuiYvonne
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yu-Jui Yvonne Wan其他文献

Genome-wide association study of the fatty liver index in the Taiwanese population reveals shared and population-specific genetic risk factors across ethnicities
  • DOI:
    10.1186/s13578-025-01346-5
  • 发表时间:
    2025-02-08
  • 期刊:
  • 影响因子:
    6.200
  • 作者:
    Pei Pei Lau;Chun-Yu Wei;Min-Rou Lin;Wan-Hsuan Chou;Yu-Jui Yvonne Wan;Wei-Chiao Chang
  • 通讯作者:
    Wei-Chiao Chang
Enrichment of nur77 mediated by retinoic acid receptor beta leads to apoptosis of human hepatocellular carcinoma cells induced by fenretinide and histone deacetylase inhibitors
视黄酸受体β介导的nur77富集导致芬维A胺和组蛋白脱乙酰酶抑制剂诱导人肝癌细胞凋亡
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    13.5
  • 作者:
    Hui Yang(杨辉);Qi Zhan;Yu-Jui Yvonne Wan
  • 通讯作者:
    Yu-Jui Yvonne Wan
Dietary contributions in the genetic variation of liver fibrosis: a genome-wide association study of fibrosis-4 index in the liver fibrosis development
  • DOI:
    10.1186/s13578-024-01321-6
  • 发表时间:
    2024-11-22
  • 期刊:
  • 影响因子:
    6.200
  • 作者:
    Poppy Diah Palupi;Chun-Yu Wei;Wan-Hsuan Chou;Min-Rou Lin;Yu-Jui Yvonne Wan;Wei-Chiao Chang
  • 通讯作者:
    Wei-Chiao Chang
Noninvasive biomarkers implicated in urea and TCA cycles for metabolic liver disease
  • DOI:
    10.1186/s40364-024-00694-7
  • 发表时间:
    2024-11-22
  • 期刊:
  • 影响因子:
    11.500
  • 作者:
    Guiyan Yang;Yu-Jui Yvonne Wan
  • 通讯作者:
    Yu-Jui Yvonne Wan
Fenretinide-induced apoptosis of Huh-7 hepatocellular carcinoma is retinoic acid receptor β dependent
  • DOI:
    10.1186/1471-2407-7-236
  • 发表时间:
    2007-12-31
  • 期刊:
  • 影响因子:
    3.400
  • 作者:
    Pengli Bu;Yu-Jui Yvonne Wan
  • 通讯作者:
    Yu-Jui Yvonne Wan

Yu-Jui Yvonne Wan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yu-Jui Yvonne Wan', 18)}}的其他基金

Liver Cancer Therapy by MiR-22 and Its Inducers
MiR-22 及其诱导剂治疗肝癌
  • 批准号:
    10556373
  • 财政年份:
    2018
  • 资助金额:
    $ 8.05万
  • 项目类别:
Liver Cancer Therapy by MiR-22 and Its Inducers
MiR-22 及其诱导剂治疗肝癌
  • 批准号:
    10330455
  • 财政年份:
    2018
  • 资助金额:
    $ 8.05万
  • 项目类别:
Liver Cancer Therapy by MiR-22 and Its Inducers
MiR-22 及其诱导剂治疗肝癌
  • 批准号:
    10094055
  • 财政年份:
    2018
  • 资助金额:
    $ 8.05万
  • 项目类别:
Retinoic Acid, Its Receptors, and the Liver
视黄酸、其受体和肝脏
  • 批准号:
    8529067
  • 财政年份:
    2011
  • 资助金额:
    $ 8.05万
  • 项目类别:
COBRE: U OF KANSAS MEDICAL CTR: MOLECULAR BIOLOGY CORE
COBRE:堪萨斯大学医学 CTR:分子生物学核心
  • 批准号:
    8360780
  • 财政年份:
    2011
  • 资助金额:
    $ 8.05万
  • 项目类别:
Retinoic Acid, Its Receptors, and the Liver
视黄酸、其受体和肝脏
  • 批准号:
    8296548
  • 财政年份:
    2011
  • 资助金额:
    $ 8.05万
  • 项目类别:
Retinoic Acid, Its Receptors, and the Liver
视黄酸、其受体和肝脏
  • 批准号:
    8465227
  • 财政年份:
    2011
  • 资助金额:
    $ 8.05万
  • 项目类别:
Retinoic Acid, Its Receptors, and the Liver
视黄酸、其受体和肝脏
  • 批准号:
    8662762
  • 财政年份:
    2011
  • 资助金额:
    $ 8.05万
  • 项目类别:
Retinoic Acid, Its Receptors, and the Liver
视黄酸、其受体和肝脏
  • 批准号:
    8205418
  • 财政年份:
    2011
  • 资助金额:
    $ 8.05万
  • 项目类别:
COBRE: U OF KANSAS MEDICAL CTR: MOLECULAR BIOLOGY CORE
COBRE:堪萨斯大学医学 CTR:分子生物学核心
  • 批准号:
    8167659
  • 财政年份:
    2010
  • 资助金额:
    $ 8.05万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 8.05万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 8.05万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 8.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 8.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 8.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 8.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 8.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 8.05万
  • 项目类别:
    Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 8.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 8.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了